Role of mpMRI in Benign Prostatic Hyperplasia Assessment and Treatment

[1] Grossfeld GD(2000)Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging Radiol Clin N Am 38 31-47

[2] Coakley FV(2019)Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction Aging Male 22 12-19

[3] Calogero AE(2016)Benign prostatic hyperplasia Nat Rev Dis Prim 2 16031-61

[4] Burgio G(2017)Targeting phenotypic heterogeneity in benign prostatic hyperplasia Differentiation. 96 49-1117

[5] Condorelli RA(2012)National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008) Urology. 79 1111-7007

[6] Cannarella R(2013)MRI characterization of the dynamic effects of 5α-reductase inhibitors on prostate zonal volumes Can J Urol 20 7002-722

[7] La Vignera S(2019)MR imaging findings of the prostate gland following prostate artery embolization: results from a prospective phase 2 study Abdom Radiol (New York) 44 713-201

[8] Chughtai B(2017)Patterns of benign prostate hyperplasia based on magnetic resonance imaging are correlated with lower urinary tract symptoms and continence in men undergoing a robot-assisted radical prostatectomy for prostate cancer Urology. 107 196-710

[9] Forde JC(2006)Benign prostatic hyperplasia: a review and ultrasound classification Radiologic Clinics 44 689-290

[10] Thomas DDM(1992)The clinical assessment of benign prostatic hyperplasia Cancer. 70 284-1643

[1] Grossfeld GD(2000)Benign prostatic hyperplasia: clinical overview and value of diagnostic imaging Radiol Clin N Am 38 31-47

[2] Coakley FV(2019)Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction Aging Male 22 12-19

[3] Calogero AE(2016)Benign prostatic hyperplasia Nat Rev Dis Prim 2 16031-61

[4] Burgio G(2017)Targeting phenotypic heterogeneity in benign prostatic hyperplasia Differentiation. 96 49-1117

[5] Condorelli RA(2012)National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008) Urology. 79 1111-7007

[6] Cannarella R(2013)MRI characterization of the dynamic effects of 5α-reductase inhibitors on prostate zonal volumes Can J Urol 20 7002-722

[7] La Vignera S(2019)MR imaging findings of the prostate gland following prostate artery embolization: results from a prospective phase 2 study Abdom Radiol (New York) 44 713-201

[8] Chughtai B(2017)Patterns of benign prostate hyperplasia based on magnetic resonance imaging are correlated with lower urinary tract symptoms and continence in men undergoing a robot-assisted radical prostatectomy for prostate cancer Urology. 107 196-710

[9] Forde JC(2006)Benign prostatic hyperplasia: a review and ultrasound classification Radiologic Clinics 44 689-290

[10] Thomas DDM(1992)The clinical assessment of benign prostatic hyperplasia Cancer. 70 284-1643